title: Development of mullerian inhibiting substance as an anti-cancer drug.
authors.forename: R L
authors.initials: RL
authors.lastname: Cate
authors.forename: E G
authors.initials: EG
authors.lastname: Ninfa
authors.forename: D J
authors.initials: DJ
authors.lastname: Pratt
authors.forename: D T
authors.initials: DT
authors.lastname: MacLaughlin
authors.forename: P K
authors.initials: PK
authors.lastname: Donahoe
mesh_terms: D000818:Animals; D054304:Anti-Mullerian Hormone; D000970:Antineoplastic Agents; D002417:Cattle; D002460:Cell Line; D003001:Cloning, Molecular; D005796:Genes; D006023:Glycoproteins; D006131:Growth Inhibitors; D006801:Humans; D008297:Male; D009095:Mullerian Ducts; D014176:Protein Biosynthesis; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013735:Testicular Hormones / Q000235:genetics / Q000627:therapeutic use*; D014158:Transcription, Genetic
chemical_list: D000970:Antineoplastic Agents; D006023:Glycoproteins; D006131:Growth Inhibitors; D011994:Recombinant Proteins; D013735:Testicular Hormones; D054304:Anti-Mullerian Hormone